Skip to main content
. 2022 Aug 15;59(3):226–231. doi: 10.29399/npa.28189

Table 2.

COVID-19 status in MS patients

Patients (n=3255)
Suspected of having COVID-19 631 (19.4%)
Tested for COVID-19 495 (15.2%)
Positive RT-PCR swab test result for COVID-19 378 (11.6%)
Being in contact with COVID-19 positive people 683 (20.9%)
Relative or family member who had COVID-19 diagnosis 420 (12.9%)
Symptoms related to the COVID-19 (n=378)
 Fatigue 183 (48.4%)
 Cough 166 (43.9%)
 Fever 152 (40.2%)
 Headache 104 (27.5%)
 Myalgia 96 (25.4%)
 Loss of smell 86 (22.7%)
 Loss of taste 80 (21.2%)
 Sore throat 78 (20.6%)
 Bone joint 74 (19.5%)
 Other 103 (27.2%)
 Hospitalization 23 (6%)

RT-PCR: Real-time PCR